GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arcturus Therapeutics Holdings Inc (NAS:ARCT) » Definitions » E10

Arcturus Therapeutics Holdings (Arcturus Therapeutics Holdings) E10 : $-5.78 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Arcturus Therapeutics Holdings E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Arcturus Therapeutics Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was $-1.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-5.78 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-09), Arcturus Therapeutics Holdings's current stock price is $31.82. Arcturus Therapeutics Holdings's E10 for the quarter that ended in Mar. 2024 was $-5.78. Arcturus Therapeutics Holdings's Shiller PE Ratio of today is .


Arcturus Therapeutics Holdings E10 Historical Data

The historical data trend for Arcturus Therapeutics Holdings's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arcturus Therapeutics Holdings E10 Chart

Arcturus Therapeutics Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - -6.77 -6.61 -6.10

Arcturus Therapeutics Holdings Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -6.51 -6.64 -6.50 -6.10 -5.78

Competitive Comparison of Arcturus Therapeutics Holdings's E10

For the Biotechnology subindustry, Arcturus Therapeutics Holdings's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Arcturus Therapeutics Holdings's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Arcturus Therapeutics Holdings's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Arcturus Therapeutics Holdings's Shiller PE Ratio falls into.



Arcturus Therapeutics Holdings E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Arcturus Therapeutics Holdings's adjusted earnings per share data for the three months ended in Mar. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-1/131.7762*131.7762
=-1.000

Current CPI (Mar. 2024) = 131.7762.

Arcturus Therapeutics Holdings Quarterly Data

per share eps CPI Adj_EPS
201406 -3.990 100.560 -5.229
201409 -5.390 100.428 -7.072
201412 -3.500 99.070 -4.655
201503 -1.820 99.621 -2.407
201506 -1.680 100.684 -2.199
201509 -1.400 100.392 -1.838
201512 -1.400 99.792 -1.849
201603 -1.260 100.470 -1.653
201606 -1.470 101.688 -1.905
201609 -1.960 101.861 -2.536
201612 -1.540 101.863 -1.992
201703 -0.910 102.862 -1.166
201706 -0.540 103.349 -0.689
201709 -1.510 104.136 -1.911
201712 -0.495 104.011 -0.627
201803 -0.660 105.290 -0.826
201806 -0.990 106.317 -1.227
201809 -0.420 106.507 -0.520
201812 -0.090 105.998 -0.112
201903 -0.680 107.251 -0.836
201906 -0.070 108.070 -0.085
201909 -0.560 108.329 -0.681
201912 -0.760 108.420 -0.924
202003 -0.670 108.902 -0.811
202006 -0.550 108.767 -0.666
202009 -0.920 109.815 -1.104
202012 -1.360 109.897 -1.631
202103 -2.150 111.754 -2.535
202106 -2.070 114.631 -2.380
202109 -2.050 115.734 -2.334
202112 -1.470 117.630 -1.647
202203 -1.940 121.301 -2.108
202206 -0.820 125.017 -0.864
202209 -1.330 125.227 -1.400
202212 4.430 125.222 4.662
202303 1.870 127.348 1.935
202306 -1.980 128.729 -2.027
202309 -0.610 129.860 -0.619
202312 -0.320 129.419 -0.326
202403 -1.000 131.776 -1.000

Add all the adjusted EPS together and divide 10 will get our e10.


Arcturus Therapeutics Holdings  (NAS:ARCT) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Arcturus Therapeutics Holdings E10 Related Terms

Thank you for viewing the detailed overview of Arcturus Therapeutics Holdings's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Arcturus Therapeutics Holdings (Arcturus Therapeutics Holdings) Business Description

Traded in Other Exchanges
N/A
Address
10628 Science Center Drive, Suite 250, San Diego, CA, USA, 92121
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
Executives
Pad Chivukula officer: Chief Scientific Officer & COO 10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO CA 92121
Keith C Kummerfeld officer: See Remarks 10628 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO CA 92121
Magda Marquet director ALTHEADX INC., 3550 DUNHILL STREET, SAN DIEGO CA 92121
John Markels director C/O SANGAMO THERAPEUTICS, INC., POINT RICHMOND TECH CTR, 501 CANAL BLVD., RICHMOND CA 94804
Joseph E Payne director, 10 percent owner, officer: President and CEO 10628 SCIENCE CENTER DRIVE, SUITE 200, SAN DIEGO CA 92121
Jing L. Marantz director C/O KRYSTAL BIOTECH, INC., 2100 WHARTON STREET, SUITE 701, PITTSBURGH PA 15203
Ultragenyx Pharmaceutical Inc. director, 10 percent owner 60 LEVERONI COURT, NOVATO CA 94949
Lance Kurata officer: Chief Legal Officer 10628 SCIENCE CENTER DRIVE, SUITE 250, SAN DIEGO CA 92121
Andy Sassine officer: Chief Financial Officer 82 DEVONSHIRE STREET, BOSTON MA 02109
Steven George Hughes officer: Chief Development Officer 6275 NANCY RIDGE DRIVE, SAN DIEGO CA 92121
James F Barlow director 2525 DUPONT DR, IRVINE CA 92612
Edward W Holmes director C/O TULARIK INC, TWO CORP DRIVE SOUTH, SAN FRANCISCO CA 8608257208
Peter C Farrell director RESMED INC, 14040 DANIELSON STREET, POWAY CA 92064-6857
Karah Herdman Parschauer director 60 LEVERONI COURT, NOVATO CA 94949

Arcturus Therapeutics Holdings (Arcturus Therapeutics Holdings) Headlines